Request for Proposals (RFP): Immunotherapy in Urothelial Carcinoma

Funding Agency:
Pfizer Inc.

Pfizer  Global Medical Grants  (GMG),  and  Merck  KGaA,  Darmstadt,  Germany  -    Global  Medical  Education  & Academic  Organization  Relations  (Global  MedEd  &  AOR)  are  collaborating  to  provide  grant  support  for continuing professional  education  and  patient  education  in  the  area  of Immuno-Oncology.   Immuno-Oncology  is a priority  for  Merck  KGaA,  Darmstadt,  Germany  and  Pfizer  Inc,  and  for the  Global  Strategic  Alliance  among  our organizations.

The intent of this RFP is to support independent education initiatives for healthcare professionals involved in the treatment of patients with locally-advanced or metastatic urothelial carcinoma (mUC), incl. oncologists, urologists, and specialty nurses.  Patient education programs designed to specifically reach patients with urothelial carcinoma and their caregivers are also in scope for this RFP. 

Grant application due date: April 12, 2022 

Agency Website

Eligibility Requirements

Geographic  Scope:

• Primary  Geographies of Interest : Europe , Asia , Latin  America

•  Secondary Geography:  Global

Note:   Applications  for  this  RFP  must  have  a  European  or Asian  or Latin  American focus.  However if a  program  also  has  a  broader  global  reach  it  would  be welcomed  and  encouraged.

The  following  may  apply: professional associations  and  medical  societies, medical,  nursing,  allied  health,  and/or pharmacy  professional schools;  healthcare institutions  (both  large  and  small);  patient  advocacy  groups,  medical  education companies;  other entities  with  a mission  related  to  healthcare  professional education  and/or  healthcare  improvement. If the  project  involves  multiple  institutions  /  organizations  /  associations  all institutions  must  have  a  relevant  role  and  the  requesting organization  must  have a  key  role in  the project.

Amount Description

The total available budget related to this RFP is approximately $775,000 USD.  The typical grant maximum under this RFP will be up to $250,000 USD for initiatives with large potential reach and impact.  

Smaller educational proposals are also encouraged.  Organizations that would like to develop activities for local or regional community healthcare professional activities or single-country patient programs should also apply.  Typically grant amounts for local or regional activities should not exceed around $50,000 USD.  

The grant amount the companies will be prepared to fund will depend upon the evaluation of the proposal and costs involved and will be stated clearly in the approval notification.  

Funding Type





Curriculum Development
International Opportunities
Medical - Clinical Science

External Deadline

April 12, 2022